Combined radioimmunotherapy and chemotherapy of breast tumors with Y-90-labeled anti-Her2 and anti-CEA antibodies with taxol.

Source:http://linkedlifedata.com/resource/pubmed/id/16173788

Download in:

View as

Triples

General Info

PMID
16173788